Insider Trading Activity For ABIOMED, Inc. (NASDAQ:ABMD)
Eric A Md Rose , Director of ABIOMED, Inc. (NASDAQ:ABMD) reportedly Sold 23,018 shares of the company’s stock at an average price of 151.09 for a total transaction amount of $3,477,789.62 SEC Form
Insider Trading History For ABIOMED, Inc. (NASDAQ:ABMD)
Analyst Ratings For ABIOMED, Inc. (NASDAQ:ABMD)
These are 1 Hold Rating, 6 Buy Ratings .
The current consensus rating for ABIOMED, Inc. (NASDAQ:ABMD) is Buy (Score: 2.86) with a consensus target price of $157.50 , a potential (6.49% upside)
Analyst Ratings History For ABIOMED, Inc. (NASDAQ:ABMD)
- On 10/29/2015 Sterne Agee CRT Reiterated Rating Buy
- On 10/30/2015 Raymond James Financial, Inc. Upgraded rating Market Perform to Outperform with a price target of $85.00
- On 4/10/2016 Benchmark Co. Reiterated Rating Buy with a price target of $145.00
- On 12/6/2016 Guggenheim Initiated Coverage of rating Buy with a price target of $150.00
- On 1/8/2017 BTIG Research Reiterated Rating Buy with a price target of $170.00
- On 3/30/2017 Leerink Swann Boost Price Target of rating Outperform with a price target of $140.00 to $150.00
- On 6/8/2017 William Blair Reiterated Rating Outperform to Outperform
Recent Trading Activity for ABIOMED, Inc. (NASDAQ:ABMD)
Shares of ABIOMED, Inc. closed the previous trading session at 147.90 up +0.23 0.16% with 295,331 shares trading hands.